Genotype-phenotype correlations in breast cancer patients showed PXR*1B to be significantly associated with lower doxorubicin clearance, suggesting that PXR haplotype constitution may be important in influencing interindividual and interethnic variations in the effects of its putative drug substrates. This evidence concerns the gene NR1I2 and breast cancer.